Chickens Poultry Medicine Bronchial Embolism Saver Bromhexine HCl Solution

Name: Chickens Poultry Medicine Bronchial Embolism Saver Bromhexine HCl Solution
Brand: Shandong Ginye Biotech Co., Ltd.
SKU: 2023236565

Shandong, ChinaShandong Ginye Biotech Co., Ltd.

US$2.00

5,000-9,999 L

US$1.90

10,000+ L

Sample price:US$2.20/bottle.Request sample

Product profile

Customization

Available

Varieties

Infectious Disease Prevention Medicine

Component

Botany

Model NO.

Compound

Type

The First Class

Pharmacodynamic Influential Factors

Repeated Medication

Storage Method

Prevent High or LowTemperature

Veterinary Reg. No.

Shouyaozhunzihao

Transport Package

Carton or Drum

Specification

1L, 5L

Trademark

Ginye

Origin

China

Production Capacity

10000L/Year

Company profile

Shandong Ginye Biotech Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2018-12-10Nearest Port: QINGDAOAverage Response Time: ≤3.21hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP

AI-Powered supplier vetting

SummaryShandong Ginye Biotech Co., Ltd. is a private trading and manufacturing company based in Shandong, China, specializing in animal pharmaceuticals and feed additives. It operates two GMP-certified factories with 10 production lines, producing over 100 products. The company exports a significant portion of its products (51%~70%) and has been active in international markets since 2018. It collaborates with several research institutions to drive innovation and has ISO 9001 and GMP certifications, indicating a strong focus on quality management.

Supplier typeThe supplier is both a trading company and a manufacturer/factory, specializing in animal pharmaceuticals and feed additives.

CertificationsThe supplier holds ISO 9001 and GMP certifications, indicating adherence to quality management and good manufacturing practices.

Financial creditThe supplier has a registered capital of 3,000,000 RMB and an annual production output between US$10 Million - US$50 Million, indicating a solid financial base.

R&D capabilityThe company emphasizes innovation and collaborates with research institutions for product development, suggesting strong innovation capability.

Production capacityThe supplier operates 10 production lines across two GMP factories, producing a diverse range of over 100 products.